Literature DB >> 9154955

Reperfusion injury in single-lung transplant recipients with pulmonary hypertension and emphysema.

A J Boujoukos1, G D Martich, J D Vega, R J Keenan, B P Griffith.   

Abstract

BACKGROUND: The early postoperative course of single-lung transplant recipients depends on the recipient's underlying lung pathophysiology and the degree of ischemic-reperfusion injury. We examined the effect of pulmonary hemodynamics and preoperative diagnosis on early allograft function and the effects of pulmonary hemodynamics, allograft blood flow, and chest radiographs on length of mechanical ventilation and intensive care unit length of stay.
METHODS: We retrospectively collected data on 30 single-lung transplant recipients, 15 each with pretransplantation pulmonary hypertension and emphysema. Blood flow to the allografts was quantitated by perfusion scans obtained on the first postoperative day. Chest radiographs were graded for reperfusion injury. Pulmonary and hemodynamic data, gas exchange parameters, duration of mechanical ventilation, and intensive care unit stay were recorded.
RESULTS: Patients with pulmonary hypertension had a prolonged intensive care unit stay compared with emphysema patients, but pulmonary artery pressures were not quantitatively related to duration of ventilation during the intensive care unit stay. There was no difference in the severity of allograft infiltrate between the emphysema and pulmonary hypertensive patients. The day 1 chest radiograph score was highly predictive of an intensive care unit stay of > or = 7 days, although the threshold score of those with pulmonary hypertension was significantly lower than in emphysema patients. Allograft blood flow and pulmonary hypertension were not contributors to early graft dysfunction. Allograft perfusion decreased with increasing radiographically demonstrated infiltrate in those with emphysema but not in those with pulmonary hypertension.
CONCLUSIONS: Elevated allograft blood flow and pressures do not exacerbate radiographically confirmed reperfusion injury. Reperfusion injury is the major cause of early respiratory morbidity after single-lung transplantation. Allograft perfusion in emphysema patients decreases in response to reperfusion injury, but pulmonary hypertension patients remain almost entirely dependent on allograft function, even with severe chest radiograph scores. This may be an important mechanism by which single-lung transplant recipients with emphysema, unlike those with pulmonary hypertension, are able to mitigate the degree of respiratory impairment associated with reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154955

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  Preoperative echocardiographic-defined moderate-severe pulmonary hypertension predicts prolonged duration of mechanical ventilation following lung transplantation for patients with COPD.

Authors:  Jeremy P Wrobel; Bruce R Thompson; Gregory I Snell; Trevor J Williams
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

2.  Risk factors for reperfusion injury after lung transplantation.

Authors:  Silvia R Cottini; Nicolas Lerch; Marc de Perrot; Miriam M Treggiari; Anastase Spiliopoulos; Laurent Nicod; Bara Ricou
Journal:  Intensive Care Med       Date:  2006-03-07       Impact factor: 17.440

3.  The outcome of lung transplantation for end-stage pulmonary diseases with pulmonary hypertension: a single-center experience.

Authors:  Shilong Wu; Guilin Peng; Chenyang Xu; Xiuhua Li; Wenfa Jiang; Qing Ai; Chao Yang; Don Xiao; Bing Wei; Weizhe Huang; Xin Xu; Jianxing He
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

4.  Preoperative cardiac variables of diastolic dysfunction and clinical outcomes in lung transplant recipients.

Authors:  Ajay Yadlapati; Joseph P Lynch; Rajan Saggar; David Ross; John A Belperio; Stephen Weigt; Abbas Ardehali; Tristan Grogan; Eric H Yang; Jamil Aboulhosn
Journal:  J Transplant       Date:  2013-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.